Riskpilot← Back to searchSign inGet full accessMedimag Konsult AB
ABActiveOrg 5592096704Ormbunksvägen 23Medical specialists activities · NACE 8622Est. 20191 employees
Revenue 2025
SEK 670K
+1% vs 2024
EBITDA margin
34.1%
+64% vs 2024
Equity ratio
49.7%
Financial strength
Net profit 2025
SEK 206K
+245% vs 2024
| Revenue | SEK 670K | +1% |
| EBITDA | SEK 229K | +64% |
| Net profit | SEK 206K | +245% |
| Total assets | SEK 558K | +2% |
| Equity | SEK 277K | +25% |
| Employees | 1 | — |
Legal name
Medimag Konsult AB
Org number
5592096704
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
19 juni 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet inom läkaryrket, tillhandahålla läkemedelskonsultation, uthyrning av läkartjänster samt bedriva medicinsk skönhetsvård. Bolaget skall även bedriva handel med värdepapper.
Address
Ormbunksvägen 23
Email
maghicielena@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 376 | 664 | 677 | 661 | 670 |
| Staff expenses | — | −45 | −56 | −31 | −32 |
| EBITDA | 176 | 278 | 345 | 139 | 229 |
| Depreciation & amort. | −0 | — | −3 | −6 | −6 |
| EBIT | 176 | 278 | 342 | 133 | 222 |
| Net financials | — | −0 | 0 | 1 | 1 |
| Profit before tax | 196 | 278 | 239 | 88 | 273 |
| Tax | −34 | −72 | −60 | −28 | −67 |
| Net profit | 162 | 206 | 180 | 60 | 206 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 391 | 407 | 572 | 549 | 558 |
| Equity | 225 | 282 | 311 | 221 | 277 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 87 | 47 | 80 | 101 | 105 |
| Total debt | 87 | 47 | 80 | 101 | 105 |
EBITDA margin
34.1%
This company
15.8%
Market median
+116% vs market
20212025
Equity ratio
49.7%
This company
38.2%
Market median
+30% vs market
20212025
Return on equity
74.4%
This company
18.4%
Market median
+304% vs market
20212025
Net profit margin
30.8%
This company
8.1%
Market median
+280% vs market
20212025
Asset turnover
1.20×
This company
1.12×
Market median
+7% vs market
20212025
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medimag Konsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cristina Elena Maghici | Board of Directors | 0 companies |
| Marcel Alin Maghici | Deputy Board Member | 0 companies |